The U.S. Food and Drug Administration (FDA) has approved two new biosimilar drugs — versions of brand-name therapies that have no clinically meaningful differences compared…
Myeloma
At my last school reunion, someone asked me, “What do you do?” “I am a writer and a columnist,” I said. At the coffee…
This September, during Blood Cancer Awareness Month, major organizations are launching new campaigns to increase awareness and support for the three main types of…
Last year, while I was attending a fundraiser for breast cancer, I watched several hundred people adorned in pink shirts cheering with joy and excitement…
The first patient has been dosed in a Phase 1 clinical trial that’s testing a gene therapy for people with recurring or treatment-resistant multiple…
Dr. A is insisting that we should start treating my mother with a new myeloma medication right away. Dr. B is asking us to wait…
When you become a caregiver, nobody warns you that you’ve also become: A Google Alert in human form, always staying up to date on…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to SAR446523, an investigational therapy being developed by Sanofi for people with…
During my mom’s last support group meeting, the facilitator asked all the participants to introduce themselves and identify their cancer by name. One after the…
Johnson & Johnson‘s Darzalex (daratumumab) is now the first approved treatment for high-risk smoldering multiple myeloma (SMM) in the European Union (EU). SMM…
